Literature DB >> 16174778

Cholecystokinin levels in prohormone convertase 2 knock-out mouse brain regions reveal a complex phenotype of region-specific alterations.

Margery C Beinfeld1, Alissa Blum, Daesety Vishnuvardhan, Sanya Fanous, James E Marchand.   

Abstract

Prohormone convertase 2 is widely co-localized with cholecystokinin in rodent brain. To examine its role in cholecystokinin processing, cholecystokinin levels were measured in dissected brain regions from prohormone convertase 2 knock-out mice. Cholecystokinin levels were lower in hippocampus, septum, thalamus, mesencephalon, and pons in knock-out mice than wild-type mice. In cerebral cortex, cortex-related structures and olfactory bulb, cholecystokinin levels were higher than wild type. Female mice were more affected by the loss of prohormone convertase 2 than male mice. The decrease in cholecystokinin levels in these brain regions shows that prohormone convertase 2 is important for cholecystokinin processing. Quantitative polymerase chain reaction measurements were performed to examine the relationship between peptide levels and cholecystokinin and enzyme expression. They revealed that cholecystokinin and prohormone convertase 1 mRNA levels in cerebral cortex and olfactory bulb were actually lower in knock-out than wild type, whereas their expression in other brain regions of knock-out mouse brain was the same as wild type. Female mice frequently had higher expression of cholecystokinin and prohormone convertase 1, 2, and 5 mRNA than male mice. The loss of prohormone convertase 2 alters CCK processing in specific brain regions. This loss also appears to trigger compensatory mechanisms in cerebral cortex and olfactory bulb that produce elevated levels of cholecystokinin but do not involve increased expression of cholecystokinin, prohormone convertase 1 or 5 mRNA.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16174778     DOI: 10.1074/jbc.M500055200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

Review 1.  Unique biological function of cathepsin L in secretory vesicles for biosynthesis of neuropeptides.

Authors:  Lydiane Funkelstein; Margery Beinfeld; Ardalan Minokadeh; James Zadina; Vivian Hook
Journal:  Neuropeptides       Date:  2010-11-02       Impact factor: 3.286

Review 2.  The endoproteolytic maturation of progastrin and procholecystokinin.

Authors:  Jens F Rehfeld
Journal:  J Mol Med (Berl)       Date:  2006-05-06       Impact factor: 4.599

Review 3.  Cysteine Cathepsins in the secretory vesicle produce active peptides: Cathepsin L generates peptide neurotransmitters and cathepsin B produces beta-amyloid of Alzheimer's disease.

Authors:  Vivian Hook; Lydiane Funkelstein; Jill Wegrzyn; Steven Bark; Mark Kindy; Gregory Hook
Journal:  Biochim Biophys Acta       Date:  2011-09-08

4.  Increased cholecystokinin labeling in the hippocampus of a mouse model of epilepsy maps to spines and glutamatergic terminals.

Authors:  M S Wyeth; N Zhang; C R Houser
Journal:  Neuroscience       Date:  2011-12-03       Impact factor: 3.590

5.  The cell-specific pattern of cholecystokinin peptides in endocrine cells versus neurons is governed by the expression of prohormone convertases 1/3, 2, and 5/6.

Authors:  Jens F Rehfeld; Jens R Bundgaard; Jens Hannibal; Xiaorong Zhu; Christina Norrbom; Donald F Steiner; Lennart Friis-Hansen
Journal:  Endocrinology       Date:  2007-12-20       Impact factor: 4.736

6.  Cathepsin L plays a major role in cholecystokinin production in mouse brain cortex and in pituitary AtT-20 cells: protease gene knockout and inhibitor studies.

Authors:  Margery C Beinfeld; Lydiane Funkelstein; Thierry Foulon; Sandrine Cadel; Kouki Kitagawa; Thomas Toneff; Thomas Reinheckel; Christoph Peters; Vivian Hook
Journal:  Peptides       Date:  2009-07-07       Impact factor: 3.750

Review 7.  Mouse Models of Human Proprotein Convertase Insufficiency.

Authors:  Manita Shakya; Iris Lindberg
Journal:  Endocr Rev       Date:  2021-05-25       Impact factor: 19.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.